Rigel Pharmaceuticals, Inc.RIGLNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$31.07M
↑ 179% above average
Average (9y)
$-39.33M
Historical baseline
Range
High:$31.07M
Low:$-77.72M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $31.07M | +249.8% |
| 2023 | $-20.74M | +72.0% |
| 2022 | $-74.21M | -1513.2% |
| 2021 | $5.25M | +109.8% |
| 2020 | $-53.45M | -24.4% |
| 2019 | $-42.97M | +28.3% |
| 2018 | $-59.93M | +22.9% |
| 2017 | $-77.72M | -1.3% |
| 2016 | $-76.69M | -220.1% |
| 2015 | $-23.96M | - |